IS5304A - For-lípósómdufttegundir til innöndunar gerðar stöðugri með tókóferóli - Google Patents

For-lípósómdufttegundir til innöndunar gerðar stöðugri með tókóferóli

Info

Publication number
IS5304A
IS5304A IS5304A IS5304A IS5304A IS 5304 A IS5304 A IS 5304A IS 5304 A IS5304 A IS 5304A IS 5304 A IS5304 A IS 5304A IS 5304 A IS5304 A IS 5304A
Authority
IS
Iceland
Prior art keywords
tocopherol
inhaled
liposome
powders stabilized
stabilized
Prior art date
Application number
IS5304A
Other languages
English (en)
Icelandic (is)
Inventor
Byström Katarina
Nilsson Per-Gunnar
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of IS5304A publication Critical patent/IS5304A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS5304A 1997-06-27 1999-12-15 For-lípósómdufttegundir til innöndunar gerðar stöðugri með tókóferóli IS5304A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88441997A 1997-06-27 1997-06-27
PCT/SE1998/001090 WO1999000111A1 (fr) 1997-06-27 1998-06-08 Poudres de proliposomes stabilisees par tocopherol et destinees a l'inhalation

Publications (1)

Publication Number Publication Date
IS5304A true IS5304A (is) 1999-12-15

Family

ID=25384589

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5304A IS5304A (is) 1997-06-27 1999-12-15 For-lípósómdufttegundir til innöndunar gerðar stöðugri með tókóferóli

Country Status (18)

Country Link
EP (1) EP1001749A1 (fr)
JP (1) JP2002510311A (fr)
KR (1) KR20010014163A (fr)
CN (1) CN1260713A (fr)
AU (1) AU729100B2 (fr)
BR (1) BR9810280A (fr)
CA (1) CA2295028A1 (fr)
EE (1) EE9900601A (fr)
HU (1) HUP0003207A3 (fr)
ID (1) ID23192A (fr)
IL (1) IL133478A0 (fr)
IS (1) IS5304A (fr)
NO (1) NO996439L (fr)
NZ (1) NZ501672A (fr)
PL (1) PL337723A1 (fr)
SK (1) SK184899A3 (fr)
TR (1) TR199903271T2 (fr)
WO (1) WO1999000111A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
EP1138311A1 (fr) * 2000-03-28 2001-10-04 Primacare S.A. Proliposomes
EP1138313A1 (fr) * 2000-03-28 2001-10-04 Primacare S.A. Proliposomes
EP1138310A1 (fr) * 2000-03-28 2001-10-04 Primacare S.A. Proliposomes
MX2007015577A (es) * 2005-06-09 2008-02-25 Biolipox Ab Metodo y composiciones para el tratamiento de trastornos inflamatorios.
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2014180827A1 (fr) * 2013-05-06 2014-11-13 Dsm Ip Assets B. V. Formulation en poudre de vitamine e
WO2016033549A2 (fr) 2014-08-28 2016-03-03 Lipocine Inc. Compositions de (17-ss)-3-oxoandrost-4-èn-17-yl tridécanoate et leurs procédés de préparation et d'utilisation
WO2016033556A1 (fr) 2014-08-28 2016-03-03 Lipocine Inc. Esters de (17-β)-hydroxy-4-androstène-3-one biodisponibles à l'état solide
CN105078963B (zh) * 2015-09-29 2018-06-22 中山大学 α-生育酚在制备治疗血吸虫病药物中的应用
US20180147215A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2081474A1 (fr) * 1990-05-08 1991-11-09 Manzer Durrani Methode de sechage par pulverisation directe de solutions de lipides et de medicaments solubles dans l'eau
AR002009A1 (es) * 1994-12-22 1998-01-07 Astra Ab Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco.

Also Published As

Publication number Publication date
CA2295028A1 (fr) 1999-01-07
HUP0003207A3 (en) 2001-03-28
KR20010014163A (ko) 2001-02-26
HUP0003207A2 (hu) 2001-02-28
WO1999000111A1 (fr) 1999-01-07
AU7945698A (en) 1999-01-19
ID23192A (id) 2000-03-23
BR9810280A (pt) 2000-09-12
AU729100B2 (en) 2001-01-25
JP2002510311A (ja) 2002-04-02
SK184899A3 (en) 2000-05-16
TR199903271T2 (en) 2000-08-21
EP1001749A1 (fr) 2000-05-24
NO996439D0 (no) 1999-12-23
PL337723A1 (en) 2000-08-28
EE9900601A (et) 2000-08-15
NO996439L (no) 2000-02-28
IL133478A0 (en) 2001-04-30
NZ501672A (en) 2001-06-29
CN1260713A (zh) 2000-07-19

Similar Documents

Publication Publication Date Title
EE04420B1 (et) Pulberinhalaator
NO990272D0 (no) Pulver-inhalator
DE69708327D1 (de) Pulverinhalator
ID24472A (id) Pembuatan aglomerat bubuk
IS2703B (is) Innöndunartæki
ID18427A (id) Pengkabut serbuk
NO2006014I1 (no) Insulin glulisin
PL340284A1 (en) Modified polypeptides dependent on vitamin k
DE69815881D1 (de) Nasaler dilatator
DE69839208D1 (de) Sintermagnet
IS5878A (is) Lyfjagjöf á duftformi til lungna
IS5304A (is) For-lípósómdufttegundir til innöndunar gerðar stöðugri með tókóferóli
DE59910394D1 (de) Gesinterter stiftheizer
DE69827484D1 (de) Stabilisierte tibolone zubereitungen
FR2763507B1 (fr) Inhalateur
DE59909297D1 (de) Carbonyleisensilizid-Pulver
DE59813144D1 (de) Teilchenmanipulierung
DE69824327D1 (de) Inhalationsgerät
DE69823490D1 (de) Antitranspirant präparat
NO20003182L (no) FremgangsmÕte for inhalering av pulverstoffer
DE69937138D1 (de) Verbundpulver
ID19844A (id) Komponen tumbukan
SE9703829D0 (sv) Powder inhaleri
DE59807895D1 (de) Pulverklarlack
IT243365Y1 (it) Inalatore migliorato